These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
189 related items for PubMed ID: 9638402
21. Hepatocellular carcinoma and hepatitis C in the United States. El-Serag HB. Hepatology; 2002 Nov; 36(5 Suppl 1):S74-83. PubMed ID: 12407579 [Abstract] [Full Text] [Related]
22. [Does interferon therapy on type C liver cirrhosis prevent the occurrence of hepatocellular carcinoma?]. Harada H, Iga D, Arisaka Y, Mitsuhashi Y, Kamitsukasa H, Yagura M, Endou H, Kawashima H. Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):754-8. PubMed ID: 7563870 [No Abstract] [Full Text] [Related]
34. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy. Shindo M, Ken A, Okuno T. Cancer; 1999 May 01; 85(9):1943-50. PubMed ID: 10223234 [Abstract] [Full Text] [Related]
36. [Treatment of hepatitis C: advances and consensus]. Lerebours E, Marcellin P, Dhumeaux D. Gastroenterol Clin Biol; 2002 Apr 01; 26 Spec No 2():B5-6. PubMed ID: 12180308 [No Abstract] [Full Text] [Related]
37. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis]. Kim MJ, Kwon OS, Chung NS, Lee SY, Jung HS, Park DK, Ku YS, Kim YK, Kim YS, Kim JH. Korean J Hepatol; 2008 Mar 01; 14(1):67-76. PubMed ID: 18367859 [Abstract] [Full Text] [Related]
38. [National survey of alcoholic liver disease in Japan]. Horie Y, Ishii H, Hibi T. Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Dec 01; 39(6):505-10. PubMed ID: 15675363 [Abstract] [Full Text] [Related]